Paroxetine Tablet, Film Coated
Product Images NDC 68071-5304

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68071-5304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5304 9)

Paroxetine 10 mg film-coated tablets label from NuCare Pharmaceuticals, Inc. The label states each tablet contains paroxetine hydrochloride equivalent to 10 mg of paroxetine. The package size is 90 tablets. Instructions include taking one tablet every 24 hours with a note to see the manufacturer's label for full ingredient details. Storage recommendation is at controlled temperature 68-77°F. The label includes various manufacturing and lot information.*

FDA Label Image

Picture1 (Image 05)

Chemical structure of paroxetine hydrochloride hemihydrate, illustrating its molecular arrangement with labeled atoms including fluorine, oxygen, and nitrogen, corresponding to the active pharmaceutical ingredient in Paroxetine 10 mg tablets by NuCare Pharmaceuticals.*

FDA Label Image

Figure (Image 06)

A pharmacokinetic (PK) chart showing fold change and 90% confidence intervals for the Cmax and AUC of several interacting drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, Phenytoin 300 mg) relative to a reference. The x-axis represents change relative to reference on a logarithmic scale from 0.1 to 10, with data points and error bars plotted for each drug and PK parameter.*

FDA Label Image

Figure2 (Image 07)

A chart showing the fold change and 90% confidence interval for pharmacokinetic parameters (Cmax and AUC) of various interacting drugs relative to a reference. The interacting drugs include Cimetidine 300 mg three times daily, Phenobarbital 100 mg once daily, Phenytoin 300 mg once daily, Digoxin 0.25 mg once daily, and Diazepam 5 mg three times daily. The x-axis represents change relative to reference from 0 to 2.*

FDA Label Image

Figure 3 (Image 08)

A pharmacokinetic chart showing fold change and 90% confidence intervals for paroxetine hydrochloride hemihydrate in populations with renal impairment (mild, moderate, severe), hepatic impairment, elderly patients at different doses (20 mg, 30 mg, 40 mg once daily), and males. Variables Cmax, Cmin, and AUC are plotted against change relative to reference values on a logarithmic scale from 0.5 to 50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.